ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      68,356.45
      0.65%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Aim Immunotech Inc (0A4Y) Quote

      Aim Immunotech Inc

      Aim Immunotech Inc (0A4Y)

      LSE
      0.00
      0.00
      (0.00%)
      Closed July 27 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      -
      Bid
      -
      Ask
      -
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      -
      Previous Close
      -
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      48,842,000
      Dividend Yield
      -
      PE Ratio
      -3.04
      Earnings Per Share (EPS)
      -0.59
      Revenue
      202k
      Net Profit
      -28.96M

      About Aim Immunotech Inc

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.aimimmuno.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Aim Immunotech Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0A4Y. The last closing price for Aim Immunotech was -. Over the last year, Aim Immunotech shares have traded in a share price range of $ 0.00 to $ 0.00.

      Aim Immunotech currently has 48,842,000 shares outstanding. Aim Immunotech has a price to earnings ratio (PE ratio) of -3.04.

      0A4Y Latest News

      More News

      AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast

      AIM ImmunoTech to Discuss First Quarter 2024 Financial Results on May 16, 2024, and Host Conference Call and Webcast OCALA, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE...

      May 09 2024
      UK Regulatory

      AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®

      AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen® OCALA, Fla., May 06, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today...

      May 06 2024
      UK Regulatory

      AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

      AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer Next safety cohort to...

      April 29 2024
      UK Regulatory

      AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer

      AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer OCALA, Fla...

      April 10 2024
      UK Regulatory

      AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

      AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update Year marked by growing body of promising data demonstrating Ampligen’s potential to address...

      April 02 2024
      UK Regulatory

      AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast

      AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast OCALA, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- AIM...

      March 26 2024
      UK Regulatory

      AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research

      AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research Data demonstrate...

      March 25 2024
      UK Regulatory

      AIM ImmunoTech Announces Launch of CEO Corner Platform

      AIM ImmunoTech Announces Launch of CEO Corner Platform CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested parties...

      March 07 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DE
      40000000DE
      120000000DE
      260000000DE
      520000000DE
      1560000000DE
      2600000000DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WINTWindtree Therapeutics Inc
      $ 8.24
      (150.46%)
      		48.57M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.1349
      (92.71%)
      		122.1k
      YIBOPlanet Image International Ltd
      $ 2.915
      (53.43%)
      		260.07k
      CREVCarbon Revolution Public Ltd
      $ 9.00
      (45.87%)
      		8.06M
      NMHINatures Miracle Holding Inc
      $ 0.2035
      (-48.06%)
      		7.69M
      TANHTantech Holdings Ltd
      $ 0.2585
      (-47.23%)
      		6.75M
      DXCMDexCom Inc
      $ 64.00
      (-40.66%)
      		53.92M
      PSIGPS International Group Ltd
      $ 1.42
      (-31.40%)
      		716.26k
      POAIPredictive Oncology Inc
      $ 1.36
      (-27.27%)
      		6.02M
      SLNASelina Hospitality PLC
      $ 0.0305
      (-18.88%)
      		408.61M
      BFIBurgerFi International Inc
      $ 0.4206
      (97.37%)
      		313.59M
      NVDANVIDIA Corporation
      $ 113.06
      (0.69%)
      		293.33M
      SQQQProShares UltraPro Short QQQ
      $ 9.10
      (-2.88%)
      		176.49M
      SGMOSangamo Therapeutics Inc
      $ 0.8612
      (28.15%)
      		123.71M

      Discussion

      View Full Feed
      SilkRoad SilkRoad 5 minutes ago
      Those are past PR’s. Read the RECENT PR’s. They are hitting all of their marks. You keep ignoring the recent good news and that is unfair.
      KBLB
      Juschilln Juschilln 7 minutes ago
      LOL!
      COOP
      snow snow 8 minutes ago
      Thanks for clarifying this question Laxmi! I suspected it referred to you. The question remains if the other party had already signed it.
      ITUP
      learningcurve2020 learningcurve2020 9 minutes ago
      "legacy schtick"? Are you really suggesting that management isn't responsible for shareholders holding their shares after the reverse split and now in such a deep in hole that they'll never climb out?
      NWBO
      Zorch305 Zorch305 10 minutes ago
      Thanks for the invite!!
      SkeBallLarry SkeBallLarry 11 minutes ago
      " That is hilarious, Capgain ~ HAGO " .. !!
      snow snow 12 minutes ago
      Dear Laxmi,

      What you write is mostly what I found too by googling some relevant topics. There are several issues here that are relevant to what is stated in cow.io. One thing is production and another thing is consumption. China is the biggest producer of rice but I take it not so muc
      ITUP
      WHITTENHALLJR WHITTENHALLJR 14 minutes ago
      Glad I sold out over a penny! Typical otc turn of events >>> sucks
      IGPK
      StormyVolcano1 StormyVolcano1 16 minutes ago
      COOP has NOTHING to do with a previous company in which escrows were given and then removed.

      No one here has an answer as to how, why and more importantly WHEN $$$$ may appear.

      It’s been 16 years a bank of this size could take 20 - 25 years to resolve.

      We
      COOP
      Louie_Louie Louie_Louie 16 minutes ago
      Watched Q-tip Yellen in the news yesterday, the non-treasurer. The woman is going door to door in all the liberal countries, on our taxpayer dollars, hyping climate change agendas. Is she or is she not "supposed" to be the Treasury Secretary? I don't think the job description says make climate ch
      trunkmonk trunkmonk 17 minutes ago
      25 by end of 25.
      FNMA
      100lbStriper 100lbStriper 17 minutes ago
      Stokd $NLST Forgot to add....the timing of Micron 294 case conclusion will be well aligned with the 912 appeal so the CAFC can hear and reconcile them together — as Sheasby preferred/asked, and as Gilstrap stated is his belief and intentions — which appears to be happening by the recently quick Fina
      NLST
      tradeherpete tradeherpete 18 minutes ago
      Let’s set aside AD as a prerequisite for getting 2-73.
      Based on its safety profile I would be interested in taking a pill that limits brain shrinkage for any reason.
      Excellent point!

      I would guess about 2 to 3 million people in the U.S. are spending about 20.00 per hr.
      AVXL
      palaypu0406 palaypu0406 18 minutes ago
      It implied, we signed the Bank Acquisition Share Purchase Agreement Yesterday Snow...
      that is hence I have explicitly used that sentence...
      ITUP
      trunkmonk trunkmonk 19 minutes ago
      No punches pulled straight forward assessment. Buuut I believe Ps, as in every other company that has Cs and Ps, has value according to the health of the commons, which is supposed to reflect the value of the company. If commons were around Par value, Ps would be worth Par territory also. thats how
      FNMAS
      100lbStriper 100lbStriper 19 minutes ago
      Stokd $NLST At the same time, and with that said....the lack of licensing/BOC issues with Micron means that briefings by parties and also Gilstrap's ruling on Micron's JMOL will carry fewer complexities, which may result in a speedier conclusion before Dec.

      I considered timing al
      NLST
      palaypu0406 palaypu0406 19 minutes ago
      I am writing a detailed note on how this math works so please allow time before commenting...Once I send the note, we can discuss..
      ITUP
      100lbStriper 100lbStriper 21 minutes ago
      Stokd $NLST While Samsung's 30 day clock from July 12 to appeal 463 case is ticking, Micron has 28 days from Final Judgment—July 11—to file post trial JMOL in 294 case. It'll progress much faster than Samsung 463 which just concluded.

      With Micron, there are no unresolved licensin
      NLST
      StayHumble StayHumble 21 minutes ago
      Power2 the P1ayers Huzzah!🟩🟩
      GME
      Wayne R Wayne R 22 minutes ago
      VIP members, stock picks of the day?


      That is just a method to suck in newbies to blow money on whatever you are pumping.

      I think you are missing the point here.

      HOW TO IMPROVE IHUB

      Not how to suck in more people into any stock you b
      EOT EOT 23 minutes ago
      “How about the PR that (falsely) stated that they were going to make their 1st delivery around Oct 16, 2022?

      “falsely”….. everything you post is false!!


      December 13, 2022 Kraig labs letter to shareholders…..

      “We first announced this partnership i
      KBLB
      palaypu0406 palaypu0406 33 minutes ago
      There is no necessity for multiple series of tokens Snow ---
      It is one "SIRI" and one "RISO"....
      SIRI
      edbi46 edbi46 34 minutes ago
      NOPAIN Act
      Jan. 1, 2025

      https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D

      Just to highlight a few points::

      (G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
      “(i) IN GENERAL.—
      SAI WBA
      IPwatcher IPwatcher 35 minutes ago
      I'm just concerned that somehow, Mr Slimeball, worked his way out of this....
      Victims can obtain his actual whereabouts using the Federal Victim notification system.
      Last I heard he remains incarcerated at the DC federal prison medical facility that he was committed to at sentencing.
      DECN

      Your Recent History

      LSE
      0A4Y
      Aim Immunotech
      LSE
      0RNP
      Avantium Holding Bv
      TG
      7FP
      Freshpet
      FX
      ZARNGN
      ZAR vs NGN
      COIN
      ASTUSD
      AirSwap
      LSE
      VOF
      Vinacapital Vietnam Oppo...
      LSE
      GCL
      Geiger Counter
      USOTC
      QBBHY
      Qube (PK)
      BIT
      F34689
      Vontobel Financial Produ...
      NYSE
      TPGH
      TPG Pace
      Delayed Upgrade Clock